ISM RESEARCH GROUP Trademark

Trademark Overview


On Monday, September 7, 2015, a trademark application was filed for ISM RESEARCH GROUP with the United States Patent and Trademark Office. The USPTO has given the ISM RESEARCH GROUP trademark a serial number of 86749257. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 22, 2018. The ISM RESEARCH GROUP trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

A pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals, namely, for treatment of AIDS, infectious diseases; a pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on humans, namely, for AIDS, infectious diseases, a pharmaceutical composition featuring a pharmaceutical carrier and an isotope selective ingredient having at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100 %, wherein the selected isotopes include stable isotopes having at least one of K-39, Mg -24, Zn...

medical services featuring a pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals featuring a pharmaceutical carrier and an isotope selective ingredient having at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of stable isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100 % and administering a first of the stable isotopes at least prior to and after surgical removal of a solid tumor to prevent possible metastases and occurrence of secondary effects and to prevent metastasizing followed by administering a second of the stable isotopes to transform a cancer cell phenotype into a normal cell, wherein the pharmaceutical carrier and an isotope selective...
ism research group

General Information


Serial Number86749257
Word MarkISM RESEARCH GROUP
Filing DateMonday, September 7, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 22, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2016

Trademark Statements


Disclaimer with Predetermined Text"RESEARCH GROUP"
Goods and ServicesA pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals, namely, for treatment of AIDS, infectious diseases; a pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on humans, namely, for AIDS, infectious diseases, a pharmaceutical composition featuring a pharmaceutical carrier and an isotope selective ingredient having at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100 %, wherein the selected isotopes include stable isotopes having at least one of K-39, Mg -24, Zn-64, Rb-85, Si-26 and combination thereof and all other isotopes, wherein the pharmaceutical carrier is in the form of a solution, a gel, a cream, a spray, an aerosol, a patch, nanoparticles, inorganic molecules, organic molecules, a plant, a fruit and a vegetable, the pharmaceutical composition for treating AIDS, infectious diseases
Goods and Servicesmedical services featuring a pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals featuring a pharmaceutical carrier and an isotope selective ingredient having at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of stable isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100 % and administering a first of the stable isotopes at least prior to and after surgical removal of a solid tumor to prevent possible metastases and occurrence of secondary effects and to prevent metastasizing followed by administering a second of the stable isotopes to transform a cancer cell phenotype into a normal cell, wherein the pharmaceutical carrier and an isotope selective ingredient having at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100 %, wherein the selected isotopes include stable isotopes having at least one of K-39, Mg -24, Zn-64, Rb-85, Si-26 and combination thereof and all other isotopes, wherein the pharmaceutical carrier is in the form of a solution, a gel, a cream, a spray, an aerosol, a patch, nanoparticles, inorganic molecules, organic molecules, a plant, a fruit and a vegetable; medical testing for diagnostics purposes for diagnosis of pathology in biological objects featuring comparative analysis of light and heavy isotopes concentrations of vital chemical elements, wherein concentrations of light and heavy isotopes are compared to the ones corresponding to a natural distribution of isotopes for a given chemical element

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 10, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 10, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMiami, FL 33109

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMiami, FL 33109

Trademark Events


Event DateEvent Description
Monday, October 22, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 22, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 20, 2018EXTENSION 3 GRANTED
Tuesday, March 20, 2018EXTENSION 3 FILED
Tuesday, March 20, 2018TEAS EXTENSION RECEIVED
Friday, September 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 20, 2017EXTENSION 2 GRANTED
Wednesday, September 20, 2017EXTENSION 2 FILED
Wednesday, September 20, 2017TEAS EXTENSION RECEIVED
Tuesday, July 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2017EXTENSION 1 GRANTED
Monday, March 20, 2017EXTENSION 1 FILED
Friday, July 14, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 20, 2017NOTICE OF REVIVAL - E-MAILED
Monday, June 19, 2017EXTENSION RECEIVED WITH TEAS PETITION
Monday, June 19, 2017PETITION TO REVIVE-GRANTED
Monday, June 19, 2017TEAS PETITION TO REVIVE RECEIVED
Monday, April 24, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 24, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 20, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 11, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 11, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 30, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 30, 2015NON-FINAL ACTION E-MAILED
Wednesday, December 30, 2015NON-FINAL ACTION WRITTEN
Friday, December 18, 2015ASSIGNED TO EXAMINER
Thursday, September 10, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 10, 2015NEW APPLICATION ENTERED IN TRAM